This pathway drives oncogenic processes, including cell cycle dysregulation and tumor progression, highlighting WTAP as both a potential therapeutic target and a prognostic indicator in hepatocellular carcinoma [69]. The gene discussed is WTAP; the disease is hepatocellular carcinoma.